Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.
Drive Innovation
January 02, 2019
Looking To JPM 2019 And A Year of Show And Tell
Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.
Our most popular articles of the year offered our predictions on disruption and the future market, and highlighted our views on healthcare reform, ACOs, and much more.
Seeing a return on investment in pharma marketing means understanding what happens to every dollar.
Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.
Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.
Purposeful collaboration will help more people understand how their daily decisions dictate their health.
How pharmaceutical companies can better define, measure, and deliver value to patients.
The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.
Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?
